Investor Presentaiton

Sustainable revenue growth over last 5 years REVENUES (Rs Cr) Well placed to harness profitable growth opportunities in the future Sustained focus on - 。 Portfolio management 。 Operations excellence 。 Science & Technology capabilities 。 Superior Commercial choices across markets Poised for growth in emerging businesses of Proprietary Products, Biologics and Aurigene +10% 15,471 14,819 13,217 11,627 9,674 FY12 FY13 FY14 FY15 FY16 FY16 global revenues of $2.4Bn Steady improvement in capital efficiency & productivity over the last five years Value in USD is calculated based on the average US dollar exchange rate

View entire presentation